Clinical Trial

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

Study acronym: STRIPE
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will explore the efficacies of several practical short-term (peri-procedural) intravenous fluid regimens in the prevention of post- endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). PEP is the most common serious ERCP-related adverse event (AE), occurring in 5-15% of patients, and associated with significant morbidity, mortality, and healthcare utilization. Given the current lack of data on effectiveness of short-term fluid regimens in PEP prevention to inform practice, the results of the proposed study have the strong potential to impact ERCP practices worldwide, whether positive or negative.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-07; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2024-12-17
Trial Details
NCT Number NCT06260878
Lead Sponsor University of Calgary
Conditions Post-ERCP Acute Pancreatitis
Enrollment 505 participants
Start Date 2024-11-22
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29